Xie Jinglong was successively rated as "Dr. Bethune" by Shijiazhuang City and Hebei Province, as an outstanding member of Hebei Province, and was awarded a special prize by the mayor. He is currently the director of the National Society of Traditional Chinese Medicine and the president of Hebei Xinle Osteomyelitis Hospital. Xie Jinglong has unique skills in treating acute and chronic osteomyelitis. Of the 20,000 patients with osteomyelitis from 3/kloc-0 provinces, municipalities and autonomous regions in China, none was amputated, with a cure rate of 95.3% and an effective rate of 99.8%. For dissolving dead bone, it is transformed into living bone to reach bone recovery period, which is one-half shorter than the national standard course of treatment and is the leading level at home and abroad.

Xie Jinglong has made remarkable achievements in scientific research. The research on the treatment of chronic suppurative osteomyelitis with traditional Chinese medicine won the second prize of scientific and technological progress in state administration of traditional chinese medicine, and the silver prize of "Shenlong Cup" in China Traditional Chinese Medicine Cultural Expo was listed as the promotion of scientific and technological achievements during the Eighth Five-Year Plan. "Traditional Chinese Medicine Treatment of Sclerosing Osteomyelitis Complicated with Sinus" and "Tuberculous Liquid Intubation Irrigation"

Dou Daoren's research on bone tuberculosis won the third prize of scientific and technological progress in Hebei Province. Xie Jinglong and his descendants Xie Zhengping and Xie Junping jointly studied "Chuangyangling (Compound Cortex Phellodendri Liquid)", which was listed as the first batch of scientific and technological achievements promotion projects during the Ninth Five-Year Plan period. Hebei Herbal Pharmaceutical Co., Ltd. has been officially put into production.

People's Daily, Health News, Guangming Daily, Science and Technology Daily, China Chinese Medicine News, provincial newspapers, CCTV, TV stations and radio stations have reported Xie Jinglong and his deeds many times.

Engaged in scientific research and clinical work of Chinese medicine surgery for more than 30 years, and achieved remarkable scientific research results. In the treatment of acute and chronic osteomyelitis, it has unique theory, unique treatment means and unique curative effect. More than 20,000 patients with osteomyelitis from 3/kloc-0 provinces, municipalities and autonomous regions in China were treated, and the cure rate reached 95.3%, without amputation. For dead bones, the course of treatment is shortened by half compared with the national standard, which is the leading level at home and abroad.

Xie Jinglong's "Research on Treating Chronic Suppurative Osteomyelitis with Traditional Chinese Medicine" won the second prize of state administration of traditional chinese medicine Science and Technology Progress Award; "China Traditional Chinese Medicine Culture Expo" won the silver prize of "Shennong Cup" and was listed as the "Eighth Five-Year Plan" for the promotion of national scientific and technological achievements; "Research on sinus therapy of bone tuberculosis" won the third prize of Hebei Science and Technology Progress Award. "Research on the treatment of sclerosing osteomyelitis complicated with sinus by traditional Chinese medicine" won the third prize of scientific and technological progress in Hebei Province.

The national new drug "Compound Huangbai Liquid" developed by it was listed as the first batch of scientific and technological achievements promotion projects during the Ninth Five-Year Plan period, and obtained the national invention certificate with the patent number ZL96 106739X, the international patent main classification number A6 1K 35/78. 1995 and the approval number (95).